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ABSTRACT  Tyrosinase, the enzyme that controls the synthesis of melanin, is a unique product 
of melanocytes. Normal and malignant human melanocytes grown  in culture  were  used to 
study the factors that regulate the expression of tyrosinase. Immunoprecipitation  experiments 
showed that newly synthesized tyrosinase appeared as a protein with an apparent molecular 
weight of 70,000 that was processed to a protein with an apparent molecular weight of 80,000. 
Neither  tunicamycin  nor  2-deoxy-D-glucose  inhibited  this  conversion,  suggesting that  O- 
glycosylation is the major biochemical event in the posttranslational modification of tyrosinase. 
Agents that  stimulated  the  proliferation  of normal melanocytes also stimulated  tyrosinase 
activity.  Melanocytes with  low levels of tyrosinase activity  synthesized less tyrosinase, proc- 
essed the enzyme  more slowly, and degraded it more rapidly than  melanocytes with  high 
levels of  tyrosinase activity.  We  conclude  that  tyrosinase activity  in  cultures  of  human 
melanocytes derived from different donors is determined  predominantly  by its abundance. 
Epidermal melanin is synthesized by melanocytes via oxida- 
tion of tyrosine. The amount of melanin in the epidermis is 
determined, at least in part, by the activity of tyrosinase. For 
example, the activity of tyrosinase is higher in foreskins taken 
from black babies than  in  foreskins taken  from caucasian 
babies (31); and melanocytes in patients with some forms of 
albinism have extremely low or no detectable tyrosinase ac- 
tivity (17).  Knowledge of factors that regulate tyrosinase is 
important because melanin protects the skin from harmful 
solar radiation. In murine melanoma cells grown in vitro the 
activity of tyrosinase is  at  least  partially  regulated by the 
intracellular  levels  of  cyclic  adenosine  monophosphate 
(cAMP). Exposure of these cells to substances that increase 
the intracellular levels of cAMP also causes an increase in 
tyrosinase activity and melanin content (1, 6-9, 22, 33, 38). 
Recently, a method for propagating normal human melano- 
cytes in vitro (5) was developed. This achievement made it 
possible to study the control of tyrosinase activity in nonma- 
lignant human melanocytes and to compare their responses 
with those of murine and human melanoma cells. Our exper- 
iments show that the activity of tyrosinase in cultured mela- 
nocytes is stimulated by agents that stimulate the growth of 
the cells and is determined by the rate of  synthesis, processing, 
and degradation of the enzyme. 
480 
MATERIALS AND  METHODS 
Materials:  Eagle's minimal essential medium (MEM) and Ham's F-10 
medium were purchased from Flow Laboratories, Inc. (McLean, VA). Sera and 
other medium supplements were  obtained from Gibeo Laboratories, Grand 
Island Biological Co. (Grand Island, NY). Culture dishes were purchased from 
Costar (Cambridge, MA). The other chemicals  were obtained from the following 
sources:  4-O-methyl-12-O-tetradecanoyl-phorbol-13-acetate  (TPA)  ~  from 
Chemicals for Cancer Research, Inc. (Eden Prairie,  MN), cholera toxin, dibu- 
tyryladenosine monophosphate, and other reagents used in enzyme assays and 
buffers from Sigma Chemical Co. (St.  Louis, MO),  L-[35S]methionine  from 
Amersham Corp.  (Arlington Heights, IL),  D-[2-aH]mannose,  D-[I,6-aH(N)]- 
glucosamine, [9,10-H(N)]palmitic  acid, [32p]orthophosphate,  sodium [S35]sul  - 
fate, L-3,5[3H]tyrosine,  and Econofluor from New England Nuclear (Boston, 
MA), DE52 resin from Pharmacia Fine Chemicals (Piscataway,  N J), IgGsorb 
from New England Enzyme Center (Boston, MA), and polyacrylamide and 
protein assay kit from Bio-Rad Laboratories (Richmond, CA). 
Culture  of  Cells:  Human  melanocytes were  grown  by  a  method 
modified from that of Eisinger and Marko (5). Foreskins from newborn babies 
were cleaned of fat and incubated at 4°C overnight (~ 18 h) in MEM without 
calcium and  supplemented with  0.25%  trypsin,  1 mM EDTA,  200  U/ml 
penicillin,  and 100 #g/ml streptomycin. The epidermis was separated from the 
dermis with  forceps.  Melanocytes were  distributed  at  the  borders of both 
segments  and became detached after vigorous  shaking  for I min. The dissociated 
t Abbreviations used in this paper: dbcAMP, dibutyryl cAMP: DOPA, 
L-dihydroxyphenylalanine: IBMX,  isobutylmethyl  xanthine;  MSH, 
melanotropin:  TCA,  trichloroacetic  acid;  TPA,  4-O-methyl-12-O- 
tetradecanoyl-phorbol- 13-acetate; IBMX, isobutylmethyl xanthine. 
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calf serum, penicillin, streptomycin,  and  10 ng/ml (16 nM) TPA and  10 nM 
cholera toxin. 
Contaminating fibroblasts and keratinocytes were removed by differential 
attachment to the culture dish. Cells were detached from the culture flasks with 
0.1% trypsin in MEM without calcium and were subcultured in growth medium 
devoid of  TPA for 30 rain at 37*(2. Most flbroblasts and keratinocytes reattached 
to the  culture  flask during this  period,  and  the  floating  melanocytes  were 
replated in medium containing  TPA and cholera toxin. Confluent  cultures of 
normal melanocytes were resuspended and seeded at a ratio of 1:3 about once 
every month. 
Human fibroblasts  obtained  from foreskins  were grown  in  Ham's F-10 
medium supplemented  with  streptomycin,  penicillin,  and  10%  calf serum. 
Human melanoma cell lines (described in reference 14), obtained from Dr. A. 
Houghton, Memorial  Sloan-Kettering Cancer Center, NY, were grown in the 
same medium. Murine melanoma cells were grown as described (6, 7). 
Metabolic Labeling of  Cells with Radioactive Com- 
pounds:  Cells  at 80% confluence in 55-cm  2 culture dishes were used. For 
labeling with [35S]methionine, they first were incubated with l0 ml of methio- 
nine-free  MEM  supplemented  with  3%  dialyzed  calf serum and  dimethy~ 
sulfoxide (DMSO) to improve uptake of the radiolabel. After 4 h, the medium 
was replaced with 1.5 ml of fresh methionine-free  medium containing  60-200 
#Ci/ml of L-[35S]methionine (1,135 Ci/mmol). The cells were incubated  for 
periods ranging from 0.5 to 6 h and harvested  immediately  or at successive 
intervals during a subsequent "chase" with nonradioactive  methionine. 
For labeling with [3H]mannosc and [3H]glucosamine, the cells were incu- 
bated in MEM with low glucose (50 rag/L) supplemented with I. 1 g/L sodium 
pyruvate, 3% dialyzed calf serum, and 1% DMSO. After 2 h, the medium was 
replaced with fresh low glucose medium supplemented  with 400 zCi/ml of O- 
[2-3H]mannose  (13  Ci/mmol) or  250  /~Ci/ml of o-[1,6-aH(N)]glucosamine 
hydrochloride (32.5 Ci/mmol) for 6 h. 
For labeling with [3H]palmitate, the cells were incubated for 24 h in growth 
medium supplemented with 3% dialyzed calf serum,  1% DMSO, and 200 zCi/ 
ml of 9,10-[aH(N)]palmitic acid (l 5.2 Ci/mmol). 
For labeling with [a2Plorthophosphate, cells were incubated for 18 h in MEM 
without inorganic phosphate  supplemented  with 3% dialyzed serum and 300 
#Ci/ml of [32PlPhosphoric acid. 
For labeling with [aSS]sulfate  cells were incubated with sulfate-free medium 
supplemented  with MgCl2, 3% dialyzed serum, and 1% DMSO. After 3 h, the 
medium was replaced with fresh sulfate-free medium supplemented  with 200 
tLCi/ml [S35]sodium sulfate for 5 h. 
Preparation of Cell Extracts:  The procedures described below were 
carried  out on ice. The labeled cells were washed  three  times with  ice-cold 
phosphate-buffered  saline (PBS) containing  methionine (2 mg/ml), or glucose 
(1  mg/ml),  scraped  into test  tubes,  and sedimented  by centrifugation.  Cells 
were lysed with  100 ul of PBS containing  1%  Nonidet  P-40 (NP-40; Sigma 
Chemical Co., Arlington Heights, IL) and 0.1 mM phenylmethylsulfonyl fluo- 
ride and agitated on a Vortex mixer (Scientific Industries, Inc., Bohemia, NY). 
The lysates were centrifuged at 16,000 g for 15 rain. To determine  the specific 
radioactivity  in protein,  10-#l aliquots  were mixed with an equal amount of 
PBS containing  0.2% bovine serum albumin (BSA), adsorbed  onto cellulose 
acetate filter paper (Whatman 3 MM, Whatman Inc., Clifton, NJ) incubated 
overnight  in cold  10%  trichloroacetic  acid (TCA) containing  methionine  or 
glucose, and washed with cold  10%  TCA and 95% ethanol.  The filters were 
scanned  in a scintillation  counter with  Econofluor  as the scintillation  fluid. 
Protein  concentrations  were determined  by the Bio-Rad  protein  assay with 
BSA as the standard. 
Preparation  of  Tyrosinase  Antisera:  Tyrosinase  purified  from 
Green's hamster melanomas  (30) was used to immunize rabbits, l ml of  purified 
enzyme solution  (100 ttg/ml) was emulsified with 2 ml of complete  Freund's 
adjuvant.  Aliquots  of 0.7  ml were injected into each rabbit  in the four foot 
pads and in three subcutaneous sites. These injections were repeated 6 wk later 
and subsequently at 3-wk intervals. Rabbits were bled monthly after the third 
injection. The rabbit antisera cross-reacted with human, chicken, and routine 
tyrosinase (Halaban, R., unpublished data). Rabbit serum obtained from Gibco 
Laboratories was used as a control. Immunoglobulins  from control and immune 
serum were purified by precipitation  with sodium sulfate and cation-exchange 
chromatography  on DE52 resin. 
Immunoprecipitation:  The following steps were carded  out on ice. 
Aliquots of  cell lysates containing  150/zg of  protein were incubated with control 
immunoglobulins for 30  min, and nonspecific  immune complexes were re- 
moved by allowing them to bind to 40 ~l of a 20% solution of formalin-treated 
Staphylococcus aureus bacteria (IgGsorb, reference 16) in PBS with 0.5% NP- 
40 for 30 min. The mixture then was centrifuged at 16,000 g for 20 rain, and 
the bacterial  pellets were discarded.  In some experiments  this procedure  was 
repeated. The final supernatant fractions were divided into two portions; one 
portion was treated with anti-tyrosinase  immunoglobulins and the other with 
control immunoglobulins  (8 ~1 of each). After 2 h, IgGsorb was added, and the 
bound immune complexes were sedimented  at 2,000 g for 6 min. To verify 
that all the enzyme was precipitated, the supernatant fractions were subjected 
to an additional  reaction  with antityrosinase  immunoglobulins.  In addition, 
aliquots  of supernatant fractions  were assayed for any remaining  tyrosinase 
activity. 
The pellets of lgGsorb with bound immune complexes were resuspended in 
PBS containing  0.5% NP-40, transferred  to clean test tubes, and centrifuged. 
This washing  procedure  was repeated  twice. The immune complexes  were 
eluted from the IgCrsorb  by heating the pellets at 100*C for 5 min in 100 #1 of 
sample buffer containing  2% SDS, 5%/~-mercaptoethanoi,  10% glycerol, 62.5 
mM Tris-HC1 (pH 6.8), and 0.001%  bromophenol blue.  The IgGsorb  was 
removed by centrifugation  at  16,000 g for 10 min, and aliquots of the super- 
natant solution were analyzed on 7.5% polyacrylamide slab gels in 0.1% SDS 
(19). The gels were stained, destained, dried, and exposed to Kodak  X-Omat 
XAR-5 film (Eastman Kodak, Rochester, NY) at -70"C. In some experiments 
the gels were prepared  for fluorography  by incubation  in Autofluor  for 2 h 
before drying. 2-ram segments were sliced from the dried gels from relevant 
radioactive bands, rehydrated with 25 ul of distilled water, and digested over- 
night with 5 ml of 5% Protosol  (National  Diagnostics, Sommerville,  NJ) in 
Econofluor at 40"C. The radioactivity  in these bands was calculated by com- 
bining the radioactive  counts in the peaks after substraction  of background 
counts.  Films  were also  scanned  with  an SU-8 spectrophotomer  (Beckman 
Instruments, Inc., Electronic Instruments Div., Shiller Park, IL). 
Electrophoresis on nondenaturing gels of partially purified tyrosinase from 
a human melanoma cell line (SK MEL 23) and immune complexes precipitated 
from normal melanocytes was carried out under similar conditions but without 
SDS. The gels were washed three times with PBS (pH 6.6) over a 30-rain period 
and incubated  with 0.2% L-dihydroxyphenylalanine (DOPA) in PBS (pH 6.8) 
at 37*(7. After 20 rain, bands corresponding to active tyrosinase became visible 
as the DOPA was converted to melanin. 
Tyrosinase  Activity  and Melanization:  Tyrosinase  activity was 
measured  (8, 9, 29) in cell extracts containing  2-60 tzg of protein  in a  final 
volume  of 200 ul in PBS containing  0.5% NP-40,  50  #M  tyrosine,  50 uM 
DOPA, and 5 #Ci/ml  [3',5'-3H]tyrosine  with a final specific activity of 0.5 Ci/ 
mmol. Measurements were made in duplicate. A unit of  tyrosinase was defined 
as the activity of enzyme that catalyzed the oxidation of 1 umol of tyrosine in 
1 min. 
To measure the extent of melanization,  cell extracts containing  20-150  ug 
of protein were heated at 90"C for 2 h in 1 ml of 0.1 N NaOH and centrifuged 
at  16,000 g  for  20  min.  The optical  density  of the supernatants  was then 
measured at 475 nm. 
Binding of B-Melanotropin to Cells:  The ability of melanocytes 
to bind ~i-melanotropin (/~MSH) was determined  as follows. Cells were har- 
vested with 0.5 mM EDTA in PBS, sedimented at 50 g, and resuspended in 5 
ml of binding buffer (15 mM HEPES in serum-free Ham's FI0 containing  5 
mg/ml BSA, pH 6.8). The cells were again pelleted and resuspended in fresh 
binding buffer and then incubated for 3 h in siliconized glass vials at 15"C in a 
shaking  water  bath  in  the  presence  of either  1 nM  [~251]/3MSH alone  (to 
determined total binding) or 1 nM [1251]~/MSH and 1 uM nonradioactive/3MSH 
(to determine  specific binding).  Melanotropin  (MSH) was purified  from pig 
pituitary glands by Dr. S. Lande. The [~2Sl]~MSH was prepared by the procedure 
of Lambert et al. (20). At the end of  the incubation period, cells were centrifuged 
for l min through discontinuous  (0.15 and 0.30 M) sucrose gradients in 400- 
#l Beckman Microfuge tubes. The supernatants  were aspirated, and the tips of 
the tubes containing the pelleted cells were cut off and measured for radioactiv- 
ity with MiniGamma counter (LKB Instruments, Inc., Rockville, MD. Human 
fibroblasts and  murine melanoma cells were used  as negative  and positive 
controls, respectively. 
RESULTS 
Tyrosinase Activity, and the Extent of 
Pigmentation in Various Cultures of Melanocytes 
The extent of pigmentation in  human beings differs, de- 
pending on the  individual genetic background.  We investi- 
gated whether such differences were also expressed in mela- 
nocytes grown in culture and whether the extent of pigmen- 
tation correlated with the level of tyrosinase activity. Tyrosin- 
ase activity and melanin content were determined in normal 
melanocytes cultured from the foreskins of 18 caucasian (C) 
and two black (B) babies and in five melanoma cell lines. The 
normal melanocyte cultures were maintained for at least 3 
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activity between normal melanocyte cultures having the high- 
est (2,000/~U/mg of protein) and lowest (20/~U/mg of protein) 
activities, but >50%  of the cultures had tyrosinase activities 
of between 200  and 400/zU/mg  of protein.  The tyrosinase 
activity  in  any  particular  culture  correlated  well  with  the 
amount of pigment extracted from the melanocytes (Fig.  l). 
Four of the melanoma cell lines were amelanotic and had no 
detectable  or  extremely  low  tyrosinase  activity;  one  was 
melanotic and had an intermediate level of tyrosinase activity 
(see Table III). 
Tyrosinase activity  in  the  murine Cloudman  $91  mela- 
noma can be increased by exposure of the cells to agents that 
raise intracellular levels of cAMP,  such as dibutyryl cAMP 
(dbcAMP), isobutylmethyl xanthine (IBMX) or MSH (1, 6- 
9, 22, 38). The effects of these agents on the tyrosinase activity 
of normal human  melanocytes are  shown in  Table  I.  The 
agents that caused a significant increase in tyrosinase activity 
were TPA,  IBMX,  and dbcAMP.  Cholera toxin had only a 
marginal effect and aMSH or/~MSH had none. The lack of 
response to MSH  was not due to the prolonged growth of 
cells in  the presence of cholera toxin.  Normal melanocytes 
grown in the absence of cholera toxin for 3 mo likewise did 
not respond to  MSH  (data  not  presented).  The  substances 
that stimulated tyrosinase activity also stimulated cell growth 
(Table I, numbers in parentheses). When TPA was not pres- 
ent, IBMX and dbcAMP were the only substances that main- 
tained the short-term growth of normal melanocytes. These 
two  substances  were  active  only  when  added  at  the  high 
concentration indicated in Table I; lower concentrations were 
ineffective  (data  not  shown).  TPA  was  the  most  effective 
growth stimulator, and in its presence none of the other agents 
caused any further increase in either the rate of growth or the 
activity of tyrosinase. Human melanoma cells grown in the 
absence of TPA  and  cholera toxin  also did  not respond to 
MSH.  The  lack  of stimulation  of tyrosinase  by  MSH  was 
observed in normal and malignant human melanocytes ex- 
pressing high or low tyrosinase activity. In contrast, tyrosinase 
activity in the murine melanoma cells was stimulated fivefold 
by the hormone. 
Binding of MSH to Human Melanocytes 
Although the human melanocytes did not respond to MSH, 
they were able to bind  [JESI]/~MSH. As  shown in  Table  II, 
normal and malignant human melanocytes bound up to 30% 
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FiGUrE  1  Correlation of tyrosinase activity and  melanin content. 
Melanin  is  expressed as the  optical  density at  475  nm  of a  cell 
lysate containing 1 mg of protein/ml. Each point represents a culture 
of melanocytes from a different foreskin. Measurements  were made 
in duplicate; standard error did not exceed 5%, 
4.82  THE JOURNAL OF CELL BIOLOGY • VOLUMr 97, 1983 
TABLE  I 
Tyrosinase Activity in Human Melanocytes Grown in the 
Presence of Various Substances 
Tyrosinase activity 
Additions to growth me- 
dium  No TPA  With TPA 
/~U/mg protein 
None  178 (56)  473 (146) 
IBMX  406 (117)  495 (149) 
aMSH  184 (56)  477 (121) 
CT  245 (52)  509 (119) 
dbcAMP  596 (84)  403 (186) 
aMSH, IBMX  454 (117)  400 (199) 
CT, IBMX  526 (110)  489 (188) 
dbcAMP, IBMX  627 (112)  424 (160) 
CT, IBMX, MSH  651  (108)  432 (207) 
CT, IBMX, dbcAMP  533 (109)  357 (212) 
Normal melanocytes (C18) were grown  in culture for 5  mo in the presence 
of TPA and cholera toxin (CT).  Cells were subjected to experimental condi- 
tions for 5 d before harvesting. Numbers in parentheses give the amount of 
protein in micrograms at the end of the experiment.  Concentrations of the 
various substances were as follows:  CT:  10 nM; aMSH: 50 nM; IBMX: 0.1 
mM; dbcAMP:  1.0 mM; TPA: 16 nM. Standard error did not exceed 10%. 
Values that differ by >20% are significantly  different from each other. 
TABLE  II 
Binding of [12Sl]I~MSH to Melanocytes and Fibroblasts 
[~2~I]/3MSH bound (cpm/mil- 
lion cells) 1 ×  10  -3 
Specific 
Cell culture  No MSH  With MSH  binding 
Normal human mela-  4.9 ±  0.98  3.4 ±  0.50 
nocytes (C80) 
Human melanoma 
cell lines 
SK MEL 13  7.8 ±  0.60  5.9 +  1.02 
SKMEL23  42.8±2.50  27.8±0.50 
SK MEL 28  2.5 ±  0.04  1.8 +  0.20 
SK MEL 37  2.5 ±  0.24  2.0 ±  0.13 
SK MEL 127  11.9 ±  0.74  8.3 ±  0.59 
Cloudman murine  25.3 ±  0.94  3.6 ±  0.05 
melanoma 
Normal human fibro-  4.0 +  0.93  4.5 ±  0.94 
blasts 
cpm/1  % of 
x  10  -~  total 
1.5  30 
1.9  24 
15.0  35 
0.7  28 
0.5  20 
3.6  30 
21.7  86 
0  0 
The assay  was performed in the presence and absence of unlabeled/~MSH 
(1  ,uM) as  described  in  Materials and  Methods.  Values are  averages  of 
triplicates _+ SD. 
of the radiolabeled BMSH in a specific manner. In contrast, 
human  fibroblasts  showed  no  specific  binding.  The  highly 
responsive  murine  Cloudman  melanoma  cells  specifically 
bound 85% of the [J25I]BMSH. 
Immunoprecipitation of Tyrosinase with 
Antityrosinase  Antibodies 
We used antityrosinase antibodies to correlate the level of 
tyrosinase activity with the amount of tyrosinase protein. The 
binding of the antibodies raised in a rabbit against tyrosinase 
purified  from  hamster melanomas was tested  with  human 
tyrosinase. Cell extracts, prepared from normal melanocytes 
(C80) metabolically labeled with [35S]methionine were reacted 
with immunoglobulins purified from either the anti-serum or 
control serum. The antityrosinase immunoglobulins precipi- 
tated  material  which  on  analysis  by  PAGE  appeared  as  a double band with an apparent molecular weight of 70,000- 
80,000. This double band was absent in control immunopre- 
cipitates (Fig. 2 A). Some proteins precipitated with both the 
antityrosinase and the control immunoglobulins. Most of this 
nonspecific binding was abolished by repeated reaction of the 
cell extracts with control immunoglobulins (see Fig.  5). The 
major radioactive band  of material precipitated specifically 
with  8  ~1 of a  solution of antityrosinase immunoglobulins 
gave the  highest  absorbance  in  the  scanning  densitometer 
(Fig.  2 B). No tyrosinase activity was detected in any of the 
supernatants of cell extracts treated with antityrosinase anti- 
bodies  and  precipitated with  IgGsorb.  In  contrast,  all  the 
activity remained  in  the  supernatants  after treatment with 
control serum (Fig. 2 C). Reaction of the supernatants already 
treated with antityrosinase antibodies with a second aliquot 
of antityrosinase antibodies did not result in additional pre- 
cipitation of tyrosinase. In control experiments, treatment of 
lysates of human  fibroblasts with  antityrosinase antibodies 
did not precipitate any material corresponding to a molecular 
weight of 70,000-80,000 (data not shown). 
The radioactive protein precipitated from normal melano- 
cytes (C80) by the antityrosinase antibodies and a sample of 
tyrosinase partially purified from a  human  melanoma cell 
line  (SK  MEL  23)  by  concanavalin  A-Agarose  (Bethesda 
Research Laboratories, Inc., Gaithersburg, MD) affinity chro- 
matography (26) were subjected to polyacrylamide  gel electro- 
phoresis under nondenaturing conditions. Fig.  3 shows  that 
the melanoma tyrosinase visualized by reacting with DOPA 
and the radioactive band from the normal melanocytes have 
the same migration pattern. 
Cellular Processing  of Newly Synthesized 
Tyrosinase 
The material precipitated by the antibodies against tyrosin- 
ase appeared to consist of  two proteins (Fig. 2A). To determine 
whether the  doublet band  on  the gel  represented proteins 
having a precursor-product relationship, normal melanocytes 
(C80) were labeled for 30 rain with [35S]methionine. As shown 
in Fig 4, one culture was harvested immediately and the other 
was  "chased" for 4  h  with nonradioactive methionine. The 
results  indicate  that  the  protein  with  the  lower molecular 
weight is synthesized first and is converted to a  protein of 
higher molecular weight. 
Tyrosinase is present in mammalian melanocytes in at least 
two, and possibly three, isozymic forms (2, 3, 1 l,  12, 27, 30, 
35).  Tyrosinase is a  glycoprotein and it has been suggested 
that the differences in the molecular weights of the isozymes 
are due to differences in the content of carbohydrates (1 l, 12, 
26). We therefore performed several experiments to determine 
whether the conversion of tyrosinase from the  light to the 
heavy form includes glycosylation. 
Cells were treated with two potent inhibitors of glycosyla- 
tion: tunicamycin (23,  34) and 2-deoxy-o-glucose (25).  The 
cells were exposed to tunicamycin (0.2  or  1.0 ~g/ml) in the 
culture medium  l  h  before the labeling period, during the 
labeling with  [35S]methionine,  and during the chase period. 
Fig. 5 shows that tunicamycin did not inhibit the synthesis or 
processing of tyrosinase. Tunicamycin may partially inhibit 
the degradation of proteins, because the specific radioactivity 
of [35S]methionine  in protein was 50% higher at the end of 
the 3-h chase period in cells treated with the drug (0.2 ~tg/ml) 
than in controls. 
2-Deoxy-o-glucose (3  mg/ml) added to the medium  3  h 
FIGURE 2  Immunoprecipitation of tyrosinase  with  antityrosinase 
antibodies. Melanocytes (C80) were incubated with medium con- 
taining 60 #Ci/ml of [~S]methionine for 4 h, and immunoprecipi- 
ration  was  carried  out  as  described  in  Materials  and  Methods. 
Tyrosinase activity of the melanocytes was 950/~U/mg of protein. 
(A) Autoradiograph of 7.5% SDS polyacrylamide slab gel. The cell 
lysate  (total  of  320  ~.g of  protein) was  divided  into eight equal 
aliquots.  To one aliquot no immunoglobulins were added (0). The 
others were immunoprecipitated with increasing concentrations of 
antityrosinase  immunoglobulins (4,  8,  16,  and  32  ~1)  or control 
immunoglobulins (4, 8, and  16 #1). The entire immunoprecipitate 
was analyzed on 7.5% SDS polyacrylamide gel, which was autora- 
diographed for 10 d. The positions of molecular  weight markers (Mr 
x  10  -3)  are shown  on  the  left.  They  included  phosphorylase  b 
(92.5), bovine serum albumin (68), ovalbumin (43), and carbonic 
anhydrase (30) (Bio-Rad Laboratories). (B) Densitometer tracings of 
the radioactive bands in A that correspond to tyrosinase. (C) Tyro- 
sinase activity in the supernatants  after precipitation of proteins 
with antibodies and  IgGsorb. Cell extracts were treated with anti- 
tyrosinase antibodies (O) or with control immunoglobulins (O). 
before and during the  labeling did inhibit the  synthesis of 
tyrosinase (Fig.  5). The specific radioactivity of [35S]methio- 
nine in protein was similar in cells treated with 2-deoxy-D- 
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mobility of tyrosinase  activity and radioactive 
immunoprecipitated tyrosinase.  Partially  puri- 
fied tyrosinase from human melanomas SK MEL 
23 (a) and tyrosinase immunoprecipitated from 
a lysate of metabolically labeled C80 cells (b) 
were subjected  to PAGE (7.5%) without SDS. 
The slab gel was incubated with 0.2% DOPA, 
dried, and exposed to film. (a) DOPA reaction 
on gel. (b) Radioactive band on film. 
itable radioactive tyrosinase after incubation of cells with 2- 
deoxy-D-glucose was the result of reduction in the amount of 
enzyme rather than reduction in the binding activity of the 
antibodies to a carbohydrate-free tyrosinase. When 2-deoxy- 
D-glucose was present only during the chase period, the mat- 
uration of tyrosinase into a heavier isozyme was not inhibited, 
but there was a  small reduction  in  the  molecular weight of 
the processed enzyme (Fig. 5). 
To  better  understand  the  effects of tunicamycin  and  2- 
deoxy-D-glucose on the processing of tyrosinase, we metabol- 
FIGURE 4  Processing  of tyrosinase. Two cultures  of C80 melano- 
cytes were metabolically labeled with [35S]methionine for 30 min. 
One  culture  was  harvested  immediately (a)  and  the  other was 
further incubated for 4 h in growth medium containing unlabeled 
methionine (b). Cell lysates were immunoprecipitated with anti- 
tyrosinase antibodies (a and b) or with control immunoglobulins  (c). 
Precipitates of control immunoglobulins with lysates of pulsed  or 
pulse-chased cells gave similar patterns of film. Immune complexes 
were separated on 7.5% SDS polyacrylamide slab gel, dried, and 
autoradiographed for 3 d. Markers (Mr x  10  -3) included phospho- 
rylase b (94), albumin (67), ovalbumin (43), carbonic anhydrase (30), 
trypsin  inhibitor (20.1), and  ~-Iactalbumin (14.4) (Pharmacia Fine 
Chemicals, Div. of Pharmacia Inc., Piscataway, N  J). 
glucose and in control cells,  indicating that the inhibition of 
synthesis of tyrosinase was not the result of a  general effect 
on synthesis of proteins. Normal melanocytes grown for 9 d 
in the presence of either 2 or 4 mM 2-deoxy-D-glucose (0.33 
and 0.67 mg/ml, respectively) had tyrosinase activity 35 and 
22%  of control,  respectively. There was a  slight  reduction 
(20%) in total protein when cells were grown in the presence 
of 4 mM 2-deoxy-D-glucose. Therefore, the absence ofprecip- 
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FIGURE 5  Effects of tunicamycin and  2-deoxy-D-glucose  on the 
synthesis and  processing of tyrosinase.  Top:  Normal melanocytes 
were metabolically labeled with [3SS]methionine for 0.5,  1, or 2 h 
(pulse). Tunicamycin, 0.2  /~g/ml  (+),  was added  1 h  before the 
beginning of the pulse; 2-deoxy-D-glucose,  3/~g/ml (+), was added 
at the beginning of the chase or 3 h before the beginning of the 
0.5-h pulse. Cells were harvested either at the end of the pulse (0) 
or were further incubated in regular medium without the radioac- 
tive amino acid for 3 or 6 h (chase). C80 melanocyte culture was 
used in the tunicamycin experiments:  the dried gel was autoradi- 
ographed for  3  d.  C8  melanocyte cultures  were used  in  the 2- 
deoxy-D-glucose  experiment. The dried gel was fluorographed for 
2 d. Tyrosinase activity and abundance in these melanocyte  cultures 
are given in Table 3. Bottom right: Radioactivity in gel slices taken 
from the dried gel of the 2-deoxy-D-glucose  experiment. 30-min 
pulse (O); 6-h chase (O); 6-h chase in the presence of 2-deoxy-D- 
glucose (x). The direction of electrophoresis is from left to right. 
Bottom left:  Normal melanocytes (B90) were metabolically labeled 
with [~H]glucosamine  (130/~Ci/ml) or [3H]mannose  (100/~Ci/ml) 
for  6  h  in  low glucose  medium  in  the absence  or  presence  of 
tunicamycin (1 /~g/ml). Cell extracts were immunoprecipitated with 
antityrosinase antibodies and subjected to polyacrylamide  gel elec- 
trophoresis as described. The dried gel was fluorographed for 14 d. 
Total radioactivity in TCA-precipitable material used in each assay 
was  675,000  and  150,000  cpm  for  glucosamine  and  mannose, 
respectively.  Radioactivity  in the tyrosinase band was 680, 420, and 
1,310 cpm in lanes a, b, and c, respectively. There was no detectable 
radioactivity above background  in lane d. ically labeled cells with [3H]mannose or [3H]glucosamine in 
the  presence or  absence  of either of these  two  inhibitors. 
Tunicamycin at 0.2 and  1.0 ~g/ml concentrations inhibited 
the incorporation of [3H]mannose into TCA-preciptable ma- 
terial by 80 and 98%, respectively. However, it did not inhibit 
the incorporation of [3H]glucosamine into TCA-preciptable 
material. In contrast, 2-deoxy-D-glucose inhibited the incor- 
poration of both  [3H]mannose and  [3H]glucosamine by 70 
and 94%, respectively. In the absence of any inhibitors, tyro- 
sinase  bound t0.1  and 0.8% of the total radioactive gluco- 
samine and mannose incorporated into glycoproteins, respec- 
tively. Tunicamycin abolished the incorporation of [3H]man- 
nose into tyrosinase, whereas incorporation of [3n]glucosa- 
mine was reduced by only 40% (Fig. 5, bottom). These results 
indicate that the glycosylation of tyrosinase proceeds by two 
different mechanisms, one sensitive and the other insensitive 
to tunicamycin. 
There was  no  incorporation of [3H]palmitate,  [32p]phos- 
phate,  or [35S]sulfate into tyrosinase (data not shown); the 
dried gels  were exposed to the  film  for 95,  35,  and  14 d, 
respectively. 
Abundance, Processing, and Degradation of 
Tyrosinase in Melanocytes Expressing Low and 
High Tyrosinase  Activity 
To determine whether tyrosinase activity correlates with 
the level of tyrosinase protein, we investigated the abundance 
and the rate of degradation of tyrosinase in cultures of mela- 
nocytes derived from different foreskins. We chose cultures 
of melanocytes having low (C9 and C33), medium (C22), and 
high (C8, B 1, and C80) activities (Table III). Cells were labeled 
metabolically by incubation with [35S]methionine  for 4 or 6 
h and then harvested immediately or at various later times. 
The rates of incorporation of pS]methionine into protein of 
each culture were similar,  as were the rates of degradation 
(data not shown). 
The labeled cells were lysed and immunoprecipitations were 
carried out. The tyrosinase precipitated from each lysate was 
analysed  by  SDS  polyacrylamide slab  gel  electrophoresis. 
These analyses are shown in Figs. 6-9. Several differences are 
seen between the results obtained from melanocytes having 
low tyrosinase activity and those obtained from melanocytes 
with high activity. 
The  cells  in  cultures  C9  and  C33,  in  which  tyrosinase 
activity is  low,  appear to  have synthesized 24-33%  of the 
amount of  enzyme produced by the cultures C8, B 1, and C80, 
in which the level of tyrosinase activity is high (Figs. 6-9 and 
Table III). C33 and C9 cells also processed tyrosinase more 
slowly and degraded it more quickly (Figs. 6-9 and Table III). 
After the initial 4-h period of labeling with [35S]methionine, 
most of the tyrosinase from C9 and C33 cells was detected 
only in the faster moving band of the doublet, whereas the 
tyrosinase from C80 cells was detected predominantly in the 
more slowly moving band (Figs. 6 and 9). In the experiments 
described above we showed that C80 cells complete the con- 
version of tyrosinase to the heavier isozyme within 3 h (Fig. 
5), whereas C33 cells require 10 h (Figs. 6 and 7). Even at the 
end of a 4-h chase following a 4-h pulse, only a fraction of 
the label in C33 cells could be found in the slow band (data 
not shown). In addition, in C33 cells, 70% of the enzyme had 
been degraded at the end of a  10-h chase period, whereas 
none was degraded during this period in C80 cells (Fig.  8). 
TABLE III 
Activity and Abundance of Tyrosinase in Melanocyte Cultures 
Abundance 
Percent 
Labeling  of total 
Activity  period  Chase  protein 
~U/mg 
protein 
Normal melanocytes 
C9  41 
C33  69 
C22  485 
C80  945 
B1  1,191 
C8  1,290 
(h) 
4  0  0.051 
4  16  0.0O8 
0.5  0  0.060 
4  0  0.062 
4  10  0.017 
4  16  0.015 
0.5  0  0.170 
0.5  6  0.180 
4  0  0.108 
4  16  0.047 
0.5  0  0.200 
O.5  2  0.410 
4  0  0.204 
4  10  0.205 
4  16  0.140 
4  0  0.190 
4  16  0.137 
0.5  0  0.220 
0.5  3  0.210 
Melanoma cells 
SK MEL 23  220  6  0  0.110 
6  16  0.055 
SK MEL 13  16  6  0  ND 
SK MEL 28  2  4  0  ND 
SK MEL 37  ND  4  0  ND 
SK MEL 127  62.5  6  0  0.013 
Cells were metabolically  labeled with [3SS]methionine for the time indicated 
and were either harvested immediately  (0 chase) or incubated  (chased) in 
regular medium  for various times. Abundance  of tyrosinase is given as the 
percent of radioactive  counts  in the tyrosinase band in slices of polyacryl- 
amide gel compared  with the total  radioactivity  of the protein used in the 
immunoprecipitation  assay.  C and B represent caucasian and black origins of 
melanocytes, respectively. ND, not detectable. 
We calculated the half-life of tyrosinase from the linear phase 
of the slopes in Fig. 8 to be 3 h in C33 and 14 h in C80 cells; 
these half-life values probably reflect the rate of degradation 
of the low vs. high molecular weight forms of the enzyme, 
respectively. 
The differences in the patterns of synthesis, processing, and 
degradation of tyrosinase were not limited to normal mela- 
nocytes. Such differences were also observed in cultures of 
human melanoma cells (Fig. 9 and Table III). Newly synthe- 
sized tyrosinase could not be detected in melanoma cells that 
had little or no measurable tyrosinase activity (Fig. 9, lanes i, 
j, m, and n, and Table III). 
Tyrosinase in cells with low activity contained the same 
amount of carbohydrates as cells with high activity. Lysates 
made of C33 and C8 cells that had been metabolically labeled 
with either [3H]mannose or [3H]glucosamine for 6 h had the 
same amount of radioactive sugar incorporated into tyrosin- 
ase (Fig.  10). Scanning densitometer analysis of the radioac- 
tive tyrosinase bands indicated that the relative intensities of 
the bands were 1.00, 1.05, 0.28, and 1.2 for lanes 1, 2, 3, and 
4  (Fig.  10), respectively. Taking into  account the  specific 
radioactivity of each carbohydrate in protein and the 3.7-fold 
HALABAN ET AL.  Regulation  of Tyrosinase in Melanocytes  485 FIGURE 6  Tyrosinase in cells with low and high tyrosinase activity. 
Cultures of melanocytes originating from caucasian donors having 
low (C33) and high (C80) tyrosinase activity were labeled with [35S] 
methionine for 4 h. They were then harvested immediately (0) or 
incubated in  regular growth medium for  10 or 16 h. Cell lysates 
were immunoprecipitated  with control immunoglobulins  (C) or with 
antityrosinase antibodies (0,  10, 16). The amount of sample buffer 
containing the eluted protein loaded on each lane was corrected 
(within each cell line) to compensate for the decrease in the specific 
radioactivity in proteins during the chase period. 
difference  in  the  abundance  of tyrosinase in  C8  compared 
with C33 cells (Table  III), it is evident that tyrosinase in C33 
cells contains carbohydrate similar in amount to that in C8 
cells. 
DISCUSSION 
Our  studies  on  human  tyrosinase give,  for the  first  time, 
values  for the abundance of the enzyme protein in melano- 
cytes. Previous studies on tyrosinase used the DOPA reaction 
for detection of  the enzyme, a technique that relies exclusively 
on the levels of enzyme activity. 
We have shown that pigmentation of normal human mel- 
anocytes derived from different donors is expressed  over a 
wide range, probably reflecting differences among individuals. 
The levels of melanization correlated positively with the levels 
of tyrosinase activity.  The activity of tyrosinase in  normal 
and malignant human melanocytes was  determined by the 
abundance of the enzymes, which in turn depended on the 
rates  of synthesis  and degradation. For example,  in C8 cells 
with 32 times more enzymatic activity,  the synthesis  of tyro- 
sinase was five times greater and degradation of the enzyme 
was four times slower than in C9 cells. This mechanism of 
regulation  of tyrosinase  activity  is  not  limited  to  human 
melanocytes; the  rate  of synthesis  of tyrosinase is  also  in- 
creased  in  murine melanoma cells stimulated by MSH and 
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FIGURE 7  Radioactivity in  immunoprecipitated tyrosinase  from 
low and high tyrosinase cells. The tyrosinase bands from the dried 
gel shown  in  Fig. 6 were excised,  rehydrated, and extracted with 
Protosol in Econofluor (5% vol/vol) at 40°C for 24 h to determine 
radioactivity. Radioactivity in tyrosinase from C33 cells (low tyrosin- 
ase activity)  is  shown  in  A  and  from  C80  cells  (high  tyrosinase 
activity) in B. Radioactivity in each gel slice is presented as a percent 
of the total radioactivity  in proteins used in the immunoprecipitation 
assay, taking into account the fraction of the sample applied to the 
gel. The total radioactivity in  protein in the immunoprecipitation 
reactions  ranged from 2.2 to 4.9  x  106 cpm. 4-h labeling period 
without chase (0), with 10-h (A) and 16-h (O) chase. The direction 
of electrophoresis is from left to right. 
03 
i 
3 
8,  01 
o  0.8 
006 --" 
0.04 
_z 
m  0.02 
I 
0  4  8  12  16  20  24 
TIME (h) 
FIGURE 8  Kinetics  of degradation of  tyrosinase,  radioactivity in 
tyrosinase precipitated from lysates of [35S]methionine-labeled cells 
was calculated from the total radioactivity in all the gel slices taken 
from tyrosinase bands such as those shown in Figs. 6 and 7. The 
data  are  expressed  as  the  percent  of  the  total  radioactivity in 
proteins used in the immunoprecipitation, taking into account the 
fraction of the sample analyzed on the gel. Averages from two to 
three experiments are  presented.  Standard error did not exceed 
10%.  High tyrosinase C80 melanocyte culture (O); low tyrosinase 
C33 melanocyte culture (O). 
dbcAMP (Halaban,  R.,  unpublished  results).  In our hands, 
the majority of the human melanoma cell lines were amelan- 
otic and had extremely low or no detectable tyrosinase activ- 
ity, and we have not yet found a normal human melanocyte 
culture that did not have melanin and a detectable tyrosinase FIGURE  9  Tyrosinase was immunoprecipitated from lysates of [3sS] 
methionine-labeled cells, analyzed on a 7.5% SDS polyacrylamide 
gel, and fluorographed. Normal  melanocytes from  different  fore- 
skins and melanoma cell lines used are as follows: B1 (a and b); C9 
(c and d); C22 (e and f); SK MEL 127 (g and h) SK MEL 28 (i, j); SK 
MEL  23  (k,  /);  SK  MEL  13  (m),  and  SK  MEL  37  (n). Cells  were 
metabolically labeled with  [35S]methionine for 4  h and  harvested 
immediately (a, c, e, g, i, k, m, and n) or chased for 16 h (b, d, f, h, 
j,  and /). Tyrosinase activity of the various cell cultures  is given in 
Table III. Dried gel was fluorographed for 1 d. 
FIGURE 10  Incorporation  of  [3H]glucosamine  and  [3H]mannose 
into tyrosinase. Extracts  of cells metabolically labeled for 6  h with 
[3H]glucosamine (250/~Ci/ml) and [3H]mannose (400/~Ci/ml) were 
used in immunoprecipitation assays. Cell lysates contained 200 ~g 
of  protein.  Approximately  3.5  times  more  [3H]glucosamine was 
incorporated into C33 than into C8 protein (1,445,000 and 411,400 
cpm  in  protein of lanes  1 and 2,  respectively) and approximately 
equal amounts of [3H]mannose (493,000 and 460,000 in protein of 
lanes 3  and 4,  respectively). The arrow  indicates the  position of 
[35S]methionine-labeled  tyrosinase precipitated from cells that were 
pulsed for 30 min with the radioactive amino acid. 
activity. This finding may indicate that, as a result of trans- 
formation, some cells synthesize less tyrosinase or that ame- 
lanotic melanocytes undergo malignant transformation more 
frequently than their melanotic counterparts. 
The newly synthesized tyrosinase of human  melanocytes 
has an apparent molecular weight of 70,000 and is converted 
within hours to a species with a molecular weight of 78,000- 
80,000.  Such conversion has also been observed in the ap- 
pearance of DOPA-reactive tyrosinase in regenerating murine 
hair bulbs (2). The molecular weight values obtained by us 
for the  human  tyrosinase are close to, but  not exactly the 
same as,  those obtained for murine tyrosinase. The murine 
isozymes T~  and T2 have molecular weights  of 81,200 and 
67,200, respectively (2, 3,  12). A third form of tyrosinase, T3 
(56,900 mol. wt.), found in murine cells (12) was not detected 
in human melanocytes. Previous experiments (12) have sug- 
gested that the processing oftyrosinase involves glycosylation. 
Treatment ofmurine T~ isozyme with neuraminidase reduced 
its molecular weight by approximately 8,000. Digestion of  the 
neuraminidase-treated T~ with/3-galactosidase or a-mannos- 
idase further reduces its molecular weight until it approaches 
that of the T3 isozyme (11).  The removal of carbohydrate 
residues from tyrosinase does not affect the enzymatic activity 
( 11, 26). Furthermore, the different isozymes are antigenically 
similar (28) and contain similar amino acids (12). Thus, the 
protein components of the isozymes are similar and suffice 
for the full expression of enzymatic activity. 
We corroborated these findings by demonstrating the in- 
corporation of [3H]mannose and [3H]glucosamine into tyro- 
sinase  and  provided further insight  into the  nature  of the 
linkage of the oligosaccharides in tyrosinase. It has been well 
established that the attachment of oligosaccharide chains to 
peptides can be by an N-glycosidic linkage from N-acetylglu- 
cosamine to the amide nitrogen of asparagine (N-glycosyla- 
tion) or by an O-glycosidic linkage to the hydroxyl group of 
serine and/or threonine (O-glycosylation) (18). Tunicamycin 
and 2-deoxy-D-glucose  are known to inhibit N-glycosylation 
by  blocking the  attachment  of the  first  sugar  residue,  N- 
acetylglucosamine to  the  lipid-carrier dolichol  monophos- 
phate, so that glycoproteins synthesized are deficient in  as- 
paragine-linked  oligosaccharides (4,  13). Although  the two 
inhibitors act in a similar fashion on other glycoproteins in 
other cellular systems, their effects on the synthesis or proc- 
essing of tyrosinase were different. 
It  is  evident  from  our  results  that  oligosaccharides are 
attached to  tyrosinase by both N-  and  O-linkage,  because 
tunicamycin inhibited the incorporation of mannose but only 
reduced the  incorporation of glucosamine  into  tyrosinase. 
Because tunicamycin did not inhibit the processing of  tyrosin- 
ase to the high molecular weight species, it is evident that this 
conversion proceeds mostly by O-glycosylation. 
The results of our experiments also indicate that there is a 
substantial lag time for the appearance of the high molecular 
weight species oftyrosinase. Thus, the processing oftyrosinase 
may be similar to that suggested for human chorionic gonad- 
otropin,  in  which  N-glycosylation occurs  cotranslationally 
and the addition of O-linked carbohydrates to the polypeptide 
occurs posttranslationally in  the  Golgi  complex (10).  It  is 
possible that the O-glycosylation of tyrosinase confers protec- 
tion against degradative enzymes, because the isozyme with 
low molecular weight in cells with low tyrosinase activity is 
degraded at a faster rate than the processed enzyme in cells 
with high tyrosinase activity. 
2-Deoxy-D-glucose inhibited  the  synthesis  of tyrosinase 
without affecting the synthesis of total protein. Inasmuch as 
2-deoxy-D-glucose is an analogue of glucose,  it might affect 
the synthesis of tyrosinase by interfering with normal sugar 
metabolism and not through its effect on glycosylation. The 
synthesis of glycoproteins in human melanocytes depend on 
the carbon source in  the medium; depriving the cells  of a 
carbon source caused a marked decrease in the incorporation 
of radioactive sugars into protein (our unpublished data). 
It also is clear that tyrosinase is not affected by three other 
posttranslational  modifications,  those  due  to  the  covalent 
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detected no incorporation of palmitic acid,  inorganic phos- 
phate, and sulfate into tyrosinase. 
Tyrosinase  activity  of  normal  human  melanocytes  was 
stimulated by substances, such as TPA, IBMX and dbcAMP, 
that  also  stimulated  cellular  proliferation.  Similar  findings 
have been reported for murine Cloudman melanoma cells (6, 
7,  32).  These murine cells require high levels of cAMP for 
maintaining a  high  rate  of proliferation and  high  levels  of 
tyrosinase activity.  It has been  reported that TPA  caused a 
sixfold increase in the content of melanin in  human mela- 
noma cells grown in culture (15).  In contrast to the findings 
in murine cells, we found tyrosinase activity and the rate of 
cellular proliferation of normal and malignant human mela- 
nocytes to be insensitive to MSH,  regardless of whether the 
cells had low or high tyrosinase activity or originated from 
black or caucasian individuals. These were unexpected find- 
ings because the administration of repeated doses of adreno- 
corticotrophic hormone or aMSH to adult human subjects is 
known to cause cutaneous hyperpigmentation within 3 d (2 l, 
24). 
The differences between responses of melanocytes to MSH 
in vivo and in vitro may be due to the fact that melanocytes 
from newborns and  malignant melanocytes do  not display 
the full range of melanocytic surface proteins present in adults 
(14).  Both  normal and  malignant  melanocytes  specifically 
bind  17-35%  of [~25I]/3MSH. This level of binding is signifi- 
cantly  higher  than  that  of  nonmelanocytic  cells,  such  as 
human fibroblasts, but is much lower than the 86%  binding 
observed in murine melanoma cells that are highly responsive 
to MSH. It is not as yet clear whether this difference reflects 
the number of receptors present on cells of different lines or 
a difference in the optimum receptor-binding conditions for 
these lines. It is possible that the lack of response to MSH in 
normal and malignant human melanocytes is due to binding 
of insufficient  numbers  of  hormone  molecules.  It  also  is 
possible that other processes known to be associated with the 
stimulation of melanization by MSH in murine melanomas, 
such as internalization of the hormone (36, 37), activation of 
adenylate cyclase (1, 22), and activation of protein kinase (9, 
22,  33), are lacking in normal human melanocytes. It also is 
possible that MSH indirectly stimulates melanization in vivo 
through a second mediator rather than by a direct action on 
the melanocytes. Studies of adult human melanocytes, pref- 
erably grown in the absence of TPA and cholera toxin, are 
needed  to  determine  similarities and  differences  in  the  re- 
sponses to MSH of human and murine normal and malignant 
melanocytes. 
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